People with chronic blood cancers called myeloproliferative neoplasms (MPN) have a significantly increased risk of stroke, heart attack, and blood clots compared to the general population. This blood clot risk is only slightly reduced by current treatment. In this study, we are exploring blood tests that may help us learn why people with MPN clot and how current MPN treatment affects those blood tests. This is a blood draw-only study.
At one visit, you will meet with a member of the study team to have 1 blood draw.
Requirements for healthy volunteers are different than for those with a specific condition. If you are interested in becoming a healthy volunteer for this study, use the below categories to determine if you are able to participate.
Mary Ellen Jones Building (UNC-Chapel Hill)
116 Manning Dr, Chapel Hill, NC 27599, USA
Brandi Reeves
Medicine-Hematology
Clinical or Medical
Observational
Healthy Volunteer or General Population
22-1203
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
